Article

  • The EMBO Journal (2008) 27, 2135 - 2146
  • doi:10.1038/emboj.2008.126

Published online: 26 June 2008

The DEAD-box helicase DDX3X is a critical component of the TANK-binding kinase 1-dependent innate immune responseEMBO Open

Didier Soulat1,a, Tilmann Bürckstümmer2,a, Sandra Westermayer1, Adriana Goncalves2, Angela Bauch2, Adrijana Stefanovic2, Oliver Hantschel2, Keiryn L Bennett2, Thomas Decker1 and Giulio Superti-Furga2

  1. Department of Infection Biology, Max F Perutz Laboratories, University of Vienna, Vienna, Austria
  2. Director's Laboratory, Research Center for Molecular Medicine, Austrian Academy of Sciences, Vienna, Austria

Correspondence to:

Thomas Decker, Max F Perutz Laboratories, Dr Bohr-Gasse 9/4, 1030 Vienna, Austria. Tel.: +43 1 427 754 605; E-mail: thomas.decker@univie.ac.at

Giulio Superti-Furga, Director's Laboratory, CeMM, Research Center for Molecular Medicine, Lazarettgasse 19, 1090 Vienna, Austria. Tel.: +43 1 401 607 0001; Fax: +43 1 401 609 70000; E-mail: gsuperti@cemm.oeaw.ac.at

aThese authors contributed equally to this work

Received 27 March 2008; Accepted 4 June 2008


TANK-binding kinase 1 (TBK1) is of central importance for the induction of type-I interferon (IFN) in response to pathogens. We identified the DEAD-box helicase DDX3X as an interaction partner of TBK1. TBK1 and DDX3X acted synergistically in their ability to stimulate the IFN promoter, whereas RNAi-mediated reduction of DDX3X expression led to an impairment of IFN production. Chromatin immunoprecipitation indicated that DDX3X is recruited to the IFN promoter upon infection with Listeria monocytogenes, suggesting a transcriptional mechanism of action. DDX3X was found to be a TBK1 substrate in vitro and in vivo. Phosphorylation-deficient mutants of DDX3X failed to synergize with TBK1 in their ability to stimulate the IFN promoter. Overall, our data imply that DDX3X is a critical effector of TBK1 that is necessary for type I IFN induction.

  • Keywords:

    • DDX3X,
    • innate immunity,
    • interferon,
    • phosphorylation,
    • TBK1

This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits distribution, and reproduction in any medium, provided the original author and source are credited. This licence does not permit commercial exploitation or the creation of derivative works without specific permission.

Top

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated

NEWS AND VIEWS

Research Highlights

Nature Immunology News and Views (01 Aug 2008)

Pin-ning down immune responses to RNA viruses

Nature Immunology News and Views (01 Jun 2006)

See all 3 matches for News And Views

The EMBO Journal is published by Nature Publishing Group on behalf of European Molecular Biology Organization